Amphetamine induces dopamine efflux through a dopamine transporter channel.
paper
Cited
Public
Unavailable
- Authors
- Kahlig, Kristopher M; Binda, Francesca; Khoshbouei, Habibeh; Blakely, Randy D; McMahon, Douglas G; Javitch, Jonathan A; Galli, Aurelio
- Year
- 2005
- Journal
- Proceedings of the National Academy of Sciences of the United States of America
- PMID
- 15728379
- DOI
- 10.1073/pnas.0407737102
- PMCID
- PMC549289
Drugs of abuse, including cocaine, amphetamine (AMPH), and heroin, elevate extracellular dopamine (DA) levels in the brain, thereby altering the activity/plasticity of reward circuits and precipitating addiction. The physiological release of DA occurs through the calcium-dependent fusion of a synaptic vesicle with the plasma membrane. Extracellular DA is cleared by uptake through the Na+/Cl- -dependent DA transporter (DAT). In contrast, the substrate AMPH induces nonvesicular release of DA mediated by DAT. Extracellular AMPH is generally believed to trigger DA efflux through DAT by facilitating exchange for cytosolic DA. Here, in outside-out patches from heterologous cells stably expressing DAT or from dopaminergic neurons, by using ionic conditions in the patch pipette that mimic those produced by AMPH stimulation, we report that AMPH causes DAT-mediated DA efflux by two independent mechanisms: (i) a slow process consistent with an exchange mechanism and (ii) a process that results in rapid (millisecond) bursts of DA efflux through a channel-like mode of DAT. Because channel-like release of DA induced by AMPH is rapid and contains a large number of DA molecules, with a single burst of DA on par with a quantum of DA from exocytotic release of a vesicle, this burst mode of release may play a role in the synaptic actions and psychostimulant properties of AMPH and related compounds. Unlike AMPH, the endogenous substrate DA, when present on both sides of the plasma membrane, inhibits this channel-like activity, thereby suggesting that the DAT channel-like mode cannot accumulate DA against a concentration gradient.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of stimulant dependence. | 2021 | 34226506 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Prefrontal circHomer1 regulates synaptic and behavioral adaptations induced by cocaine. | Chen Y et al. | β | 2026 | β |
| Neurochemical alterations in monoaminergic systems induced by excessive sucrose consumption from the juvenile period to adolescence in mice. | Choe WH et al. | β | 2025 | β |
| Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies. | Solomon MB et al. | β | 2025 | β |
| TNF-Ξ± signaling mediates the dopaminergic effects of methamphetamine by stimulating dopamine transporters and L-type Ca<sup>2+</sup> channels. | Lin LM et al. | β | 2025 | β |
| Trace amine-associated receptor 1 agonists differentially regulate dopamine transporter function. | Huey JK et al. | β | 2025 | β |
| Using miniscopes and deep learning to compare neurobehavioral representations of psychostimulant and opioid self-administration. | Broomer MC et al. | β | 2025 | β |
| Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site. | Pedersen CN et al. | β | 2024 | β |
| Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function-Not a New Concept, but Neglected Reality. | Salvatore MF | β | 2024 | β |
| Effect of altered production and storage of dopamine on development and behavior in <i>C. elegans</i>. | Lee I et al. | β | 2024 | β |
| Immunity on ice: The impact of methamphetamine on peripheral immunity. | Miller EJ et al. | β | 2024 | β |
| MDMA for treatment of PTSD and neurorehabilitation in military populations. | Dunn W et al. | β | 2024 | β |
| Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons. | Yun S et al. | β | 2023 | β |
| CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson's disease. | Pakarinen E et al. | β | 2023 | β |
| CNTN1 in the Nucleus Accumbens is Involved in Methamphetamine-Induced Conditioned Place Preference in Mice. | Zhang L et al. | β | 2023 | β |
| Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release. | Keighron JD et al. | β | 2023 | β |
| Repeated chemogenetic activation of dopaminergic neurons induces reversible changes in baseline and amphetamine-induced behaviors. | Chohan MO et al. | β | 2023 | β |
| Syntaxin 1 Ser<sup>14</sup> phosphorylation is required for nonvesicular dopamine release. | Shekar A et al. | β | 2023 | β |
| Amphetamine-induced neurite injury in PC12 cells through inhibiting GAP-43 pathway. | Yan X et al. | β | 2022 | β |
| A novel microRNA, novel-m009C, regulates methamphetamine rewarding effects. | Zhu L et al. | β | 2022 | β |
| Functional characterization of the biogenic amine transporters on human macrophages. | Mackie PM et al. | β | 2022 | β |
| Substance abuse and neurotransmission. | Davis S et al. | β | 2022 | β |
| The Lepidopteran KAAT1 and CAATCH1: Orthologs to Understand Structure-Function Relationships in Mammalian SLC6 Transporters. | Castagna M et al. | β | 2022 | β |
| Assessment of the abuse potential of methamnetamine in rodents: a behavioral pharmacology study. | Youn DH et al. | β | 2021 | β |
| Descriptors of Secondary Active Transporter Function and How They Relate to Partial Reactions in the Transport Cycle. | Schicker K et al. | β | 2021 | β |
| Dopamine System, NMDA Receptor and EGF Family Expressions in Brain Structures of Bl6 and 129Sv Strains Displaying Different Behavioral Adaptation. | Varul J et al. | β | 2021 | β |
| Dopamine Transporter Is a Master Regulator of Dopaminergic Neural Network Connectivity. | Miller DR et al. | β | 2021 | β |
| Dynamic control of the dopamine transporter in neurotransmission and homeostasis. | Bu M et al. | β | 2021 | β |
| Genome-wide association study of stimulant dependence. | Cox J et al. | β | 2021 | β |
| Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity. | Miller DR et al. | β | 2021 | β |
| Modulating D1 rather than D2 receptor-expressing spiny-projection neurons corresponds to optimal antipsychotic effect | Yun S et al. | β | 2021 | β |
| Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia. | Aguilar JI et al. | β | 2021 | β |
| Regulation of Glutamate, GABA and Dopamine Transporter Uptake, Surface Mobility and Expression. | Ryan RM et al. | β | 2021 | β |
| Altered baseline and amphetamine-mediated behavioral profiles in dopamine transporter Cre (DAT-Ires-Cre) mice compared to tyrosine hydroxylase Cre (TH-Cre) mice. | Chohan MO et al. | β | 2020 | β |
| Differential genetic risk for methamphetamine intake confers differential sensitivity to the temperature-altering effects of other addictive drugs. | Mootz JRK et al. | β | 2020 | β |
| Electrical Stimulation Evokes Rotational Behavior In Tandem with Exocytotic-like Increases in Dopamine Measured by In Vivo Intracerebral Microdialysis. | Grant AH et al. | β | 2020 | β |
| In Situ Regulated Dopamine Transporter Trafficking: There's No Place Like Home. | Fagan RR et al. | β | 2020 | β |
| Molecular Mechanisms of Amphetamines. | Reith MEA et al. | β | 2020 | β |
| Functional Selectivity and Partial Efficacy at the Monoamine Transporters: A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release. | Hasenhuetl PS et al. | β | 2019 | β |
| G protein Ξ²Ξ³ subunits play a critical role in the actions of amphetamine. | Mauna JC et al. | β | 2019 | β |
| Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters. | Mulvihill KG | β | 2019 | β |
| A kinetic account for amphetamine-induced monoamine release. | Hasenhuetl PS et al. | β | 2018 | β |
| DARK Classics in Chemical Neuroscience: Ibogaine. | Wasko MJ et al. | β | 2018 | β |
| Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action. | Karam CS et al. | β | 2018 | β |
| Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans. | White TL et al. | β | 2018 | β |
| Quantitative Assessment of the Energetics of Dopamine Translocation by Human Dopamine Transporter. | Cheng MH et al. | β | 2018 | β |
| Structural basis for recognition of diverse antidepressants by the human serotonin transporter. | Coleman JA et al. | β | 2018 | β |
| The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease. | Mackie P et al. | β | 2018 | β |
| The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction. | Sambo DO et al. | β | 2018 | β |
| A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence. | Alexander PD et al. | β | 2017 | β |
| Crosstalk between insulin and dopamine signaling: A basis for the metabolic effects of antipsychotic drugs. | Nash AI | β | 2017 | β |
| Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters. | Solis E | β | 2017 | β |
| GΞ²Ξ³ subunit activation promotes dopamine efflux through the dopamine transporter. | Garcia-Olivares J et al. | β | 2017 | β |
| HIV, Tat and dopamine transmission. | Gaskill PJ et al. | β | 2017 | β |
| N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability. | Solis E et al. | β | 2017 | β |
| Phospho-specific antibodies targeting the amino terminus of the human dopamine transporter. | Karam CS et al. | β | 2017 | β |
| Potential role of tyrosine hydroxylase in the loss of psychostimulant effect of amphetamine under conditions of impaired dopamine transporter activity. | Janenaite E et al. | β | 2017 | β |
| Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion. | Castro-HernΓ‘ndez J et al. | β | 2017 | β |
| Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids. | Covey DP et al. | β | 2016 | β |
| Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking. | Phillips TJ et al. | β | 2016 | β |
| Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane. | Richardson BD et al. | β | 2016 | β |
| Sex-related differences in striatal dopaminergic system after traumatic brain injury. | Xu X et al. | β | 2016 | β |
| Amphetamines, new psychoactive drugs and the monoamine transporter cycle. | Sitte HH et al. | β | 2015 | β |
| Computational modeling of the N-terminus of the human dopamine transporter and its interaction with PIP2 -containing membranes. | Khelashvili G et al. | β | 2015 | β |
| Dopaminergic and cholinergic modulation of striatal tyrosine hydroxylase interneurons. | IbÑñez-Sandoval O et al. | β | 2015 | β |
| Dopamine Transporter Activity Is Modulated by Ξ±-Synuclein. | Butler B et al. | β | 2015 | β |
| Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops. | Khelashvili G et al. | β | 2015 | β |
| Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding. | Cheng MH et al. | β | 2015 | β |
| Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse. | Korpi ER et al. | β | 2015 | β |
| mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission. | Dadalko OI et al. | β | 2015 | β |
| Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. | German CL et al. | β | 2015 | β |
| Spontaneous inward opening of the dopamine transporter is triggered by PIP2-regulated dynamics of the N-terminus. | Khelashvili G et al. | β | 2015 | β |
| Structural analysis of dopamine- and amphetamine-induced depolarization currents in the human dopamine transporter. | Tang QY et al. | β | 2015 | β |
| The structure and function of the dopamine transporter and its role in CNS diseases. | McHugh PC et al. | β | 2015 | β |
| An investigation of cigarettes smoking behavior and nicotine dependence among Chinese methamphetamine users in two provinces. | Wang Z et al. | β | 2014 | β |
| A quantitative model of amphetamine action on the 5-HT transporter. | Sandtner W et al. | β | 2014 | β |
| Bath salts and synthetic cathinones: an emerging designer drug phenomenon. | German CL et al. | β | 2014 | β |
| Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia. | Baladi MG et al. | β | 2014 | β |
| Drosophila melanogaster as a genetic model system to study neurotransmitter transporters. | Martin CA et al. | β | 2014 | β |
| Future pharmacological treatments for substance use disorders. | Forray A et al. | β | 2014 | β |
| Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). | Blum K et al. | β | 2014 | β |
| Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. | Mergy MA et al. | β | 2014 | β |
| Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders. | Gowrishankar R et al. | β | 2014 | β |
| Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing. | Saha K et al. | β | 2014 | β |
| Reptation-induced coalescence of tunnels and cavities in Escherichia Coli XylE transporter conformers accounts for facilitated diffusion. | Cunningham P et al. | β | 2014 | β |
| SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. | Bowton E et al. | β | 2014 | β |
| The amphetamine sensitization model of schizophrenia symptoms and its effect on schedule-induced polydipsia in the rat. | Hawken ER et al. | β | 2014 | β |
| The dopamine transporter expression level differentially affects responses to cocaine and amphetamine. | Cagniard B et al. | β | 2014 | β |
| The potential for misuse and abuse of medications in ADHD: a review. | Clemow DB et al. | β | 2014 | β |
| The transport mechanism of the human sodium/myo-inositol transporter 2 (SMIT2/SGLT6), a member of the LeuT structural family. | Sasseville LJ et al. | β | 2014 | β |
| A case of amelioration of venlafaxine-discontinuation "brain shivers" with atomoxetine. | Cortes JA et al. | β | 2013 | β |
| Amphetamine's dose-dependent effects on dorsolateral striatum sensorimotor neuron firing. | Ma S et al. | β | 2013 | β |
| A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder. | Upadhyaya HP et al. | β | 2013 | β |
| Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. | Cameron KN et al. | β | 2013 | β |
| Combinational effects of ketamine and amphetamine on behaviors and neurotransmitter systems of mice. | Lai CC et al. | β | 2013 | β |
| De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. | Hamilton PJ et al. | β | 2013 | β |
| Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor. | Haleem DJ | β | 2013 | β |
| Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release. | Rickhag M et al. | β | 2013 | β |
| Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. | Panenka WJ et al. | β | 2013 | β |
| Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. | Perfeito R et al. | β | 2013 | β |
| The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells. | Roth JA et al. | β | 2013 | β |
| The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities. | Timple JM et al. | β | 2013 | β |
| The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila. | Pizzo AB et al. | β | 2013 | β |
| 4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP+) is a fluorescent substrate for the human serotonin transporter. | Solis E et al. | β | 2012 | β |
| Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options. | Hodgkins P et al. | β | 2012 | β |
| Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization. | German CL et al. | β | 2012 | β |
| Closing the gap between clinic and cage: sensori-motor and cognitive behavioural testing regimens in neurotoxin-induced animal models of Parkinson's disease. | Pienaar IS et al. | β | 2012 | β |
| Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study. | Hysek CM et al. | β | 2012 | β |
| Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. | Vearrier D et al. | β | 2012 | β |
| Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits. | Minzenberg MJ | β | 2012 | β |
| Phosphatidylinositol 4,5-biphosphate (PIP(2)) lipids regulate the phosphorylation of syntaxin N-terminus by modulating both its position and local structure. | Khelashvili G et al. | β | 2012 | β |
| Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse. | Perfeito R et al. | β | 2012 | β |
| S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis. | Rodriguez-Menchaca AA et al. | β | 2012 | β |
| Single cell measurement of dopamine release with simultaneous voltage-clamp and amperometry. | Saha K et al. | β | 2012 | β |
| The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. | Bulling S et al. | β | 2012 | β |
| The solute carrier 6 family of transporters. | BrΓΆer S et al. | β | 2012 | β |
| Toxicity of amphetamines: an update. | Carvalho M et al. | β | 2012 | β |
| Unifying concept of serotonin transporter-associated currents. | Schicker K et al. | β | 2012 | β |
| Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo. | Ramsson ES et al. | β | 2011 | β |
| A multivariate assessment of individual differences in sensation seeking and impulsivity as predictors of amphetamine self-administration and prefrontal dopamine function in rats. | Marusich JA et al. | β | 2011 | β |
| Binge cocaine administration in adolescent rats affects amygdalar gene expression patterns and alters anxiety-related behavior in adulthood. | Daws SE et al. | β | 2011 | β |
| Dopamine release mediated by the dopamine transporter, facts and consequences. | Leviel V | β | 2011 | β |
| High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat. | Ramsson ES et al. | β | 2011 | β |
| How addictive drugs disrupt presynaptic dopamine neurotransmission. | Sulzer D | β | 2011 | β |
| Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. | Leinninger GM et al. | β | 2011 | β |
| Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration. | Rodriguez JS et al. | β | 2011 | β |
| The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. | Hysek CM et al. | β | 2011 | β |
| Ξ±-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. | Swant J et al. | β | 2011 | β |
| Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation. | Seger D | β | 2010 | β |
| Dopamine transporter trafficking: rapid response on demand. | Chen R et al. | β | 2010 | β |
| Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. | Bowton E et al. | β | 2010 | β |
| Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. | Lipina TV et al. | β | 2010 | β |
| Lewy body pathology in fetal grafts. | Chu Y et al. | β | 2010 | β |
| Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum. | Scheidweiler KB et al. | β | 2010 | β |
| Reassessment of models of facilitated transport and cotransport. | Naftalin RJ | β | 2010 | β |
| Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. | Eriksen J et al. | β | 2010 | β |
| Stimulants and doping in sport. | Thevis M et al. | β | 2010 | β |
| The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango. | Sitte HH et al. | β | 2010 | β |
| Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine. | Field JR et al. | β | 2010 | β |
| Using In Vivo Electrochemistry to Study the Physiological Effects of Cocaine and Other Stimulants on the Drosophila melanogaster Dopamine Transporter. | Makos MA et al. | β | 2010 | β |
| A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. | Robertson SD et al. | β | 2009 | β |
| Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo. | Goodwin JS et al. | β | 2009 | β |
| Amphetamine-evoked rotation requires newly synthesized dopamine at 14 days but not 1 day after intranigral 6-OHDA and is consistently dissociated from sensorimotor behavior. | Paquette MA et al. | β | 2009 | β |
| Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats. | Yu PL et al. | β | 2009 | β |
| Cholinergic functioning in stimulant addiction: implications for medications development. | Sofuoglu M et al. | β | 2009 | β |
| Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity. | Price DA et al. | β | 2009 | β |
| Drosophila vesicular monoamine transporter mutants can adapt to reduced or eliminated vesicular stores of dopamine and serotonin. | Simon AF et al. | β | 2009 | β |
| Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia. | Olsson SK et al. | β | 2009 | β |
| Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. | Mosharov EV et al. | β | 2009 | β |
| Introducing tetraCys motifs at two different sites results in a functional dopamine transporter. | Orun O et al. | β | 2009 | β |
| Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. | Capela JP et al. | β | 2009 | β |
| Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons. | Guillot TS et al. | β | 2009 | β |
| Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens. | Richards TL et al. | β | 2009 | β |
| The impact of cigarette smoking on stimulant addiction. | Weinberger AH et al. | β | 2009 | β |
| Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. | Daws LC | β | 2009 | β |
| Behavioral genetic contributions to the study of addiction-related amphetamine effects. | Phillips TJ et al. | β | 2008 | β |
| Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. | Cunha-Oliveira T et al. | β | 2008 | β |
| Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function. | Sershen H et al. | β | 2008 | β |
| Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. | Erreger K et al. | β | 2008 | β |
| Dopamine dysregulation syndrome. Hypothetical application of reward system stimulation for the treatment of anhedonia in Parkinson's disease patients. | Kondo T | β | 2008 | β |
| Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. | Carvelli L et al. | β | 2008 | β |
| Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization. | Cen X et al. | β | 2008 | β |
| PI3K signaling supports amphetamine-induced dopamine efflux. | Lute BJ et al. | β | 2008 | β |
| Pre-filtering improves reliability of Affymetrix GeneChips results when used to analyze gene expression in complex tissues. | Greco D et al. | β | 2008 | β |
| Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. | Zhu J et al. | β | 2008 | β |
| Secretory vesicle rebound hyperacidification and increased quantal size resulting from prolonged methamphetamine exposure. | Markov D et al. | β | 2008 | β |
| Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. | Binda F et al. | β | 2008 | β |
| Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers. | Joyce BM et al. | β | 2007 | β |
| Cocaine-but not methamphetamine-associated memory requires de novo protein synthesis. | Kuo YM et al. | β | 2007 | β |
| Distribution of the dopamine innervation in the macaque and human thalamus. | GarcΓa-Cabezas MA et al. | β | 2007 | β |
| Early stress and chronic methylphenidate cross-sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens. | Jezierski G et al. | β | 2007 | β |
| Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition. | Pedersen K et al. | β | 2007 | β |
| Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors. | Korotkova TM et al. | β | 2007 | β |
| New insights into the mechanism of action of amphetamines. | Fleckenstein AE et al. | β | 2007 | β |
| Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1. | Wu Y et al. | β | 2007 | β |
| Perturbation of dopamine metabolism by 3-amino-2-(4'-halophenyl)propenes leads to increased oxidative stress and apoptotic SH-SY5Y cell death. | Samms WC et al. | β | 2007 | β |
| Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice. | Ji J et al. | β | 2007 | β |
| Simple transporter trafficking model for amphetamine-induced dopamine efflux. | Thwar PK et al. | β | 2007 | β |
| Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. | Trzaska KA et al. | β | 2007 | β |
| The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits. | Volz TJ et al. | β | 2007 | β |
| Transporters as channels. | DeFelice LJ et al. | β | 2007 | β |
| Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. | John CE et al. | β | 2007 | β |
| Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. | Fog JU et al. | β | 2006 | β |
| Currents in neurotransmitter transporters. | Gerstbrein K et al. | β | 2006 | β |
| Differential cytotoxic responses of PC12 cells chronically exposed to psychostimulants or to hydrogen peroxide. | Cunha-Oliveira T et al. | β | 2006 | β |
| Getting the message across: a recent transporter structure shows the way. | Henry LK et al. | β | 2006 | β |
| Impact of basic FGF expression in astrocytes on dopamine neuron synaptic function and development. | Forget C et al. | β | 2006 | β |
| Na+, Cl-, and pH dependence of the human choline transporter (hCHT) in Xenopus oocytes: the proton inactivation hypothesis of hCHT in synaptic vesicles. | Iwamoto H et al. | β | 2006 | β |
| Nigral injection of antisense oligonucleotides to synaptotagmin I using HVJ-liposome vectors causes disruption of dopamine release in the striatum and impaired skill learning. | Akita H et al. | β | 2006 | β |
| Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum. | Nowak P et al. | β | 2006 | β |
| Regulation of the dopamine transporter by phosphorylation. | Foster JD et al. | β | 2006 | β |
| Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine. | Kunnathur V et al. | β | 2006 | β |
| Synthesis, protein levels, activity, and phosphorylation state of tyrosine hydroxylase in mesoaccumbens and nigrostriatal dopamine pathways of chronically food-restricted rats. | Pan Y et al. | β | 2006 | β |
| The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current. | Binda F et al. | β | 2006 | β |
| Biogenic amine neurotransmitter transporters: just when you thought you knew them. | Blakely RD et al. | β | 2005 | β |
| Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates. | Zhen J et al. | β | 2005 | β |
| Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation. | Gorentla BK et al. | β | 2005 | β |
| How did the neurotransmitter cross the bilayer? A closer view. | Sonders MS et al. | β | 2005 | β |
| Mechanisms of neurotransmitter release by amphetamines: a review. | Sulzer D et al. | β | 2005 | β |
| Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. | Johnson LA et al. | β | 2005 | β |
| Role of monoamine transporters in mediating psychostimulant effects. | Riddle EL et al. | β | 2005 | β |
| Safety of obesity drugs. | Greenway FL et al. | β | 2005 | β |
| Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. | Hilber B et al. | β | 2005 | β |
| The primate thalamus is a key target for brain dopamine. | SΓ‘nchez-GonzΓ‘lez MA et al. | β | 2005 | β |